AU545279B2 - Retarded release pharmaceutical compositions - Google Patents

Retarded release pharmaceutical compositions

Info

Publication number
AU545279B2
AU545279B2 AU72069/81A AU7206981A AU545279B2 AU 545279 B2 AU545279 B2 AU 545279B2 AU 72069/81 A AU72069/81 A AU 72069/81A AU 7206981 A AU7206981 A AU 7206981A AU 545279 B2 AU545279 B2 AU 545279B2
Authority
AU
Australia
Prior art keywords
component
melting
finely divided
pharmaceutical compositions
melting point
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU72069/81A
Other languages
English (en)
Other versions
AU7206981A (en
Inventor
Helmut Augart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6105792&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU545279(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of AU7206981A publication Critical patent/AU7206981A/en
Application granted granted Critical
Publication of AU545279B2 publication Critical patent/AU545279B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU72069/81A 1980-06-28 1981-06-23 Retarded release pharmaceutical compositions Expired AU545279B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE30244167 1980-06-28
DE3024416A DE3024416C2 (de) 1980-06-28 1980-06-28 Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung

Publications (2)

Publication Number Publication Date
AU7206981A AU7206981A (en) 1982-01-07
AU545279B2 true AU545279B2 (en) 1985-07-11

Family

ID=6105792

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72069/81A Expired AU545279B2 (en) 1980-06-28 1981-06-23 Retarded release pharmaceutical compositions

Country Status (15)

Country Link
US (1) US4483847A (enExample)
EP (1) EP0043254B1 (enExample)
JP (1) JPS5738711A (enExample)
AT (1) ATE7655T1 (enExample)
AU (1) AU545279B2 (enExample)
CA (1) CA1165691A (enExample)
DD (1) DD159966A5 (enExample)
DE (2) DE3024416C2 (enExample)
DK (1) DK155711C (enExample)
ES (1) ES503414A0 (enExample)
FI (1) FI76928C (enExample)
HU (1) HU184862B (enExample)
IE (1) IE51353B1 (enExample)
SU (1) SU1360575A3 (enExample)
ZA (1) ZA814094B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU579012B2 (en) * 1985-05-09 1988-11-10 Rhone-Poulenc Sante Compositions for the preparation of microparticles permitting a prolonged release of a biologically active substance

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5959632A (ja) * 1982-09-28 1984-04-05 Teikoku Chem Ind Corp Ltd 徐放性組成物
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
JPS6150912A (ja) * 1984-08-16 1986-03-13 Shionogi & Co Ltd リポソ−ム製剤の製造法
US4755387A (en) * 1985-03-21 1988-07-05 The Procter & Gamble Company Therapeutic particles
US4820523A (en) * 1986-04-15 1989-04-11 Warner-Lambert Company Pharmaceutical composition
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
JP2668880B2 (ja) * 1987-06-23 1997-10-27 日本油脂株式会社 被覆アミノ酸類の製造方法
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
US5134016A (en) * 1990-10-31 1992-07-28 E. I. Du Pont De Nemours And Company Fiber reinforced porous sheets
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5792474A (en) * 1992-05-22 1998-08-11 Goedecke Aktiengesellschaft Process for the production of retarded pharmaceutical compositions
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US7740881B1 (en) 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1996031197A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
DE19522899C1 (de) * 1995-06-23 1996-12-19 Hexal Pharmaforschung Gmbh Verfahren zum kontinuierlichen Ersintern eines Granulats
CA2234957C (en) * 1995-10-17 2006-12-19 Inge B. Henriksen Insoluble drug delivery
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
ES2201673T3 (es) * 1998-02-11 2004-03-16 Rtp Pharma Corporation Combinacion de esteroides y acidos grasos poiinsaturados para el tratamiento de estados inflamatorios.
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
US8415329B1 (en) 1998-05-29 2013-04-09 Jagotec Ag Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations
CN1221249C (zh) 1998-08-19 2005-10-05 斯凯伊药品加拿大公司 普鲁泊福的可注射水分散体
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
HUP0105089A3 (en) 1998-11-20 2002-09-30 Skyepharma Canada Inc Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
KR20020011985A (ko) * 1999-05-07 2002-02-09 파르마솔 게엠베하 액상 및 고체상 지질 혼합물에 기초한 지질입자들 및 그의제조방법
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
KR100889069B1 (ko) 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
EP1276465B1 (en) 2000-04-20 2014-03-12 Jagotec AG Improved water-insoluble drug particle process
JP4969761B2 (ja) 2000-08-31 2012-07-04 オバン・エナジー・リミテッド 所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
HU230686B1 (en) 2000-10-30 2017-08-28 Euro Celtique Sa Controlled release hydrocodone compositions
IL156532A0 (en) * 2000-12-27 2004-01-04 Ares Trading Sa Lipid microparticles, their preparation and pharmaceutical compositions containing them
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
WO2004069138A2 (en) 2003-02-03 2004-08-19 Novartis Ag Pharmaceutical formulation
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
RU2267318C1 (ru) * 2004-05-25 2006-01-10 Закрытое акционерное общество "ФАРМАПЭК" Пролонгированный антиангинальный препарат изосорбида динитрата и способ его получения
ES2653568T3 (es) 2004-06-12 2018-02-07 Collegium Pharmaceutical, Inc. Formulaciones de fármacos para la prevención del abuso
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
AU2007275034A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophilic abuse deterrent delivery system
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
EP2240167B1 (en) * 2007-12-21 2013-11-13 Ludwig-Maximilians-Universität Extruded rod-shaped devices for controlled release of biological substances in humans and animals
WO2009092601A1 (en) 2008-01-25 2009-07-30 Grünenthal GmbH Pharmaceutical dosage form
NZ588863A (en) 2008-05-09 2012-08-31 Gruenenthal Chemie Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
JP5667183B2 (ja) 2009-07-22 2015-02-12 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 加熱溶融押出成型した制御放出性投与剤型
ES2718688T3 (es) 2009-07-22 2019-07-03 Gruenenthal Gmbh Forma de dosificación resistente a la manipulación para opioides sensibles a la oxidación
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
CN102821757B (zh) 2010-02-03 2016-01-20 格吕伦塔尔有限公司 通过挤出机制备粉末状药物组合物
CN103269688A (zh) 2010-09-02 2013-08-28 格吕伦塔尔有限公司 包含无机盐的抗破碎剂型
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
NO2736497T3 (enExample) 2011-07-29 2018-01-20
EP2736495B1 (en) 2011-07-29 2017-08-23 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
TR201815502T4 (tr) 2012-04-18 2018-11-21 Gruenenthal Gmbh Kurcalama veya dirençli ve doz boşalımına dirençli farmasötik dozaj formu.
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US10154966B2 (en) 2013-05-29 2018-12-18 Grünenthal GmbH Tamper-resistant dosage form containing one or more particles
MX2015016254A (es) 2013-05-29 2016-04-20 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
JP2017516789A (ja) 2014-05-26 2017-06-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エタノール過量放出に対して防護されている多粒子
PL3188713T5 (pl) * 2014-08-11 2024-07-29 Perora Gmbh Sposób wywoływania uczucia sytości
HK1246173A1 (zh) 2015-04-24 2018-09-07 Grünenthal GmbH 具有立即释放和对溶剂萃取的抗性的抗篡改剂型
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CA3043494C (en) 2016-11-10 2022-11-08 Medisca Pharmaceutique Inc. Pharmaceutical compounding methods and systems
EP3492070A1 (en) * 2017-11-30 2019-06-05 BIT Pharma GmbH Process and device for preparing a solid dispersion

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2875130A (en) * 1956-11-20 1959-02-24 Smith Kline French Lab Method of preparing sustained release particles and the product of the method
GB906422A (en) * 1958-05-02 1962-09-19 Wellcome Found Improvements in and relating to prolonged acting pharmaceutical preparations
US3108046A (en) * 1960-11-25 1963-10-22 Smith Kline French Lab Method of preparing high dosage sustained release tablet and product of this method
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
US3279998A (en) * 1962-06-22 1966-10-18 Smith Kline French Lab Method of preparing sustained release tablets
GB1021924A (en) * 1962-06-22 1966-03-09 Smith Kline French Lab Improvements in or relating to method of preparing sustained release tablets
US3308217A (en) * 1965-02-09 1967-03-07 Lowy Lawrence Method of granulating materials for subsequent forming into tablets
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
DE1617418C3 (de) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
SE335202B (enExample) * 1968-06-19 1971-05-17 Aco Laekemedel Ab
GB1312918A (en) * 1969-07-08 1973-04-11 Beecham Group Ltd Veterinary treatment
DK121813B (da) * 1969-12-10 1971-12-06 C Mangen Fremgangsmåde til fremstilling af tabletlignende doseringsenheder.
DE2426811A1 (de) * 1974-06-04 1976-01-08 Klinge Co Chem Pharm Fab Verfahren zur herstellung von retard-tabletten

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU579012B2 (en) * 1985-05-09 1988-11-10 Rhone-Poulenc Sante Compositions for the preparation of microparticles permitting a prolonged release of a biologically active substance

Also Published As

Publication number Publication date
EP0043254B1 (en) 1984-05-30
ES8301625A1 (es) 1983-01-01
DE3163868D1 (en) 1984-07-05
DE3024416A1 (de) 1982-01-21
IE811438L (en) 1981-12-28
ES503414A0 (es) 1983-01-01
JPS6140204B2 (enExample) 1986-09-08
HU184862B (en) 1984-10-29
ZA814094B (en) 1982-07-28
JPS5738711A (en) 1982-03-03
DK155711C (da) 1989-10-23
ATE7655T1 (de) 1984-06-15
DK155711B (da) 1989-05-08
DD159966A5 (de) 1983-04-20
EP0043254A1 (en) 1982-01-06
SU1360575A3 (ru) 1987-12-15
DE3024416C2 (de) 1982-04-15
FI811951L (fi) 1981-12-29
AU7206981A (en) 1982-01-07
CA1165691A (en) 1984-04-17
FI76928B (fi) 1988-09-30
DK278381A (da) 1981-12-29
FI76928C (fi) 1989-01-10
IE51353B1 (en) 1986-12-10
US4483847A (en) 1984-11-20

Similar Documents

Publication Publication Date Title
AU545279B2 (en) Retarded release pharmaceutical compositions
HUT34891A (en) Process for producing compositions with controlled dissolution of active ingredients
AU1718276A (en) Fuel composition and method of manufacture
PT76919B (en) Process for preparing pharmaceutical mixture compositions with controlled release of active substance
GB1513166A (en) Method of making granules
IL59943A (en) Polymerizable compositions containing half esters of organic polyols,process for their preparation and molded articles prepared therefrom
AU5708980A (en) Dispersions of high melting polyesters in polyhydroxyl compounds and polyurethanes based on them
PT71050A (en) Process for the preparation of 6-substituted pyranone derivates and their use as pharmaceuticals compositions
ES8103043A1 (es) Procedimiento para la obtencion de derivados de 2-hidroxime-til-3,4,5-trihidroxipiperidinas
ZM5376A1 (en) Method of independently adjusting the fuel mixture composition and melting rate of multiburner shaft furnaces for melting metals
ZA792043B (en) Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
JPS5638386A (en) Method of adjusting mixing proportion of coals for coke production
PT71049A (en) Process for the preparation of 6-substituted pyranone derivates and their use as pharmaceuticals compositions
JPS52782A (en) Process for production of magnetic fluid
DE3071449D1 (en) Process for the manufacture of mixed phosphoric acid ester compositions and plasticised polymers containing them
JPS5615652A (en) Production of porous candy gum
ES491306A0 (es) Procedimiento para la preparacion de motitas coloreadas apropiadas para su incorporacion en un polvo para lavar
KE2709A (en) Pyrimidin(2)yl-thionophosphoric acid esters, process for their preparation and their use as insecticides, acaricides and nematocides
JPS51137704A (en) Process for pr eparing powdered fats and oils
JPS52142696A (en) Production of dicalcium silicate powder
JPS5247509A (en) Production process of silicomanganese
JPS5664746A (en) Production of molded cheese that is packed in a vessel
EP0015544A3 (en) Derivatives of the mercaptopropionamido-acetic acid, process for the preparation thereof and compositions
JPS5382772A (en) Preparation of isoindolinone derivs.
JPS53134778A (en) Preparation of single crystal having incongruent composition

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired